Bivalirudin: no benefit over unfractionated heparin in PCI

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1652, 2008-01, pp. : 12-12

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Bivalirudin a break-through for bleeding in PCI

By  

Inpharma, Vol. 1, Iss. 1632, 2008-01 ,pp. : 14-14

Adis International

Access to resources Recommend Favorite

Bleeding complications of unfractionated heparin

By Krishnaswamy Amar   Lincoff A Michael   Cannon Christopher P  

Expert Opinion on Drug Safety, Vol. 10, Iss. 1, 2011-01 ,pp. : 77-84

Informa Healthcare

Access to resources Recommend Favorite

Bivalirudin brings benefit to treatment of STEMI

By  

Inpharma, Vol. 1, Iss. 1661, 2008-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Fixed-dose unfractionated heparin comparable to LMWH for thromboembolism

By  

Inpharma, Vol. 1, Iss. 1552, 2006-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Bivalirudin benefit independent of GPIIb-IIIa antagonists

By  

Inpharma, Vol. 1, Iss. 1632, 2008-01 ,pp. : 21-21

Adis International

Access to resources Recommend Favorite